(Reuters) - Health insurer Cigna Group is in exclusive talks to sell its Medicare Advantage business to Health Care Service Corp for between $3 billio.
Cigna is close to a $4 0 billion deal to sell Medicare Advantage unit invezz.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from invezz.com Daily Mail and Mail on Sunday newspapers.
CVS Health said on Wednesday
it will remove AbbVie’s blockbuster rheumatoid
arthritis drug Humira from some of its lists of preferred drugs
for reimbursement as of April 1, and will recommend.
CVS Health said on Wednesday it will remove AbbVie’s blockbuster rheumatoid arthritis drug Humira from some of its lists of preferred drugs for reimbursement as of April 1, and will recommend biosimilar versions of the medicine instead. CVS said Hyrimoz and an unbranded version of Humira, both from Swiss drugmaker Sandoz, will be covered across all its formularies, while branded and unbranded near copies of the drug from India's Biocon will be covered on some reimbursement lists. CVS also announced that AbbVie and CVS-owned company Cordavis, which launched in August, will produce a co-branded version of Humira that will be made available to customers in the second quarter of this year.